A Single and Multiple Ascending Dose Study of BMS-986318 in Healthy Participants
- Status
- WITHDRAWN
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
Study of Safety and Tolerability of Nivolumab Treatment Alone or in Combination With Relatlimab or Ipilimumab in Head and Neck Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Neoadjuvant Nivolumab + Palbociclib + Anastrozole in Post-Menopausal Women and Men With Primary Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy of Re-challenge With Immune-Checkpoints Inhibitors in Advanced Non-Small-Cell Lung Cancer Patients: a Retrospective Observational Study
- Status
- COMPLETED
- Phase
- N/A
A Study to Evaluate the Safety, Tolerability, Kinetics and Repeatability of 18F-BMS-986327
- Status
- COMPLETED
- Phase
- PHASE1
Treg Modulation With CD28 and IL-6 Receptor Antagonists
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets
- Status
- COMPLETED
- Phase
- PHASE1
Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)
- Status
- TERMINATED
- Phase
- PHASE2
Ivosidenib (AG-120) With Nivolumab in IDH1 Mutant Tumors
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
The SMART CART Study: Health Information Technology
- Status
- COMPLETED
- Phase
- NA
A Study of Nivolumab in Patients With Head and Neck Cancer.
- Status
- COMPLETED
- Phase
- N/A
SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Assess the Effectiveness of an Atrial Fibrillation (AF) Risk Prediction Algorithm and Diagnostic Test in Identifying Patients With AF.
- Status
- COMPLETED
- Phase
- N/A
Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan
- Status
- COMPLETED
- Phase
- N/A
SBRT as a Vaccination for Metastatic Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE3